BIOL
Biolase, Inc.
BIOL
BIOL
Delisted
BIOL was delisted on the 18th of June, 2024.
12 hedge funds and large institutions have $199K invested in Biolase, Inc. in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
12
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$95.4K | |
| 2 | +$44.3K | |
| 3 | +$19.4K | |
| 4 |
Walleye Capital
New York
|
+$5.08K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.87K |
Top Sellers
| 1 | -$67K | |
| 2 | -$38.5K | |
| 3 | -$28.8K | |
| 4 |
TSS
Two Sigma Securities
New York
|
-$11.4K |
| 5 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$11K |